Cargando…

Presence of ´isolated´ tricuspid regurgitation should prompt the suspicion of heart failure with preserved ejection fraction

BACKGROUND: Diastolic dysfunction of the left ventricle is common but frequently under-diagnosed. Particularly in advanced stages affected patients may present with significant functional tricuspid regurgitation (TR) as the most prominent sign on echocardiography. The underlying left ventricular pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mascherbauer, Julia, Kammerlander, Andreas A., Zotter-Tufaro, Caroline, Aschauer, Stefan, Duca, Franz, Dalos, Daniel, Winkler, Susanne, Schneider, Matthias, Bergler-Klein, Jutta, Bonderman, Diana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5310868/ https://www.ncbi.nlm.nih.gov/pubmed/28199339 http://dx.doi.org/10.1371/journal.pone.0171542

Ejemplares similares

Gender-related differences in heart failure with preserved ejection fraction
por: Duca, Franz, et al.
Publicado: (2018)

Serum levels of gamma-glutamyltransferase predict outcome in heart failure with preserved ejection fraction
por: Dalos, Daniel, et al.
Publicado: (2019)

Outcome in Heart Failure with Preserved Ejection Fraction: The Role of Myocardial Structure and Right Ventricular Performance
por: Goliasch, Georg, et al.
Publicado: (2015)

Pulmonary artery to aorta ratio for the detection of pulmonary hypertension: cardiovascular magnetic resonance and invasive hemodynamics in heart failure with preserved ejection fraction
por: Karakus, Gültekin, et al.
Publicado: (2015)

Persistent atrial fibrillation in heart failure with preserved ejection fraction: Prognostic relevance and association with clinical, imaging and invasive haemodynamic parameters
por: Schönbauer, Robert, et al.
Publicado: (2019)

Extracellular volume quantification by cardiac magnetic resonance imaging without hematocrit sampling: Ready for prime time?
por: Kammerlander, Andreas A., et al.
Publicado: (2017)

Patients with Heart Failure and Preserved Ejection Fraction Are at Risk of Gastrointestinal Bleeding
por: Schrutka, Lore, et al.
Publicado: (2019)

Prognostic Impact of Tricuspid Regurgitation in Patients Undergoing Aortic Valve Surgery for Aortic Stenosis
por: Mascherbauer, Julia, et al.
Publicado: (2015)

Prevalence and prognostic significance of right ventricular systolic dysfunction in heart failure with preserved ejection fraction. Insights from a cardiac magnetic resonance imaging study
por: Aschauer, Stefan, et al.
Publicado: (2015)

Impact of Systemic Volume Status on Cardiac Magnetic Resonance T1 Mapping
por: Antlanger, Marlies, et al.
Publicado: (2018)

Extracellular matrix expansion by cardiac magnetic resonance T1 mapping- validation with myocardial biopsy
por: Kammerlander, Andreas, et al.
Publicado: (2015)

Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial( )
por: Dachs, Theresa Marie, et al.
Publicado: (2022)

Prognostic impact of left atrial function in heart failure with preserved ejection fraction in sinus rhythm vs. persistent atrial fibrillation
por: Schönbauer, Robert, et al.
Publicado: (2021)

Sex Differences in Left Ventricular Remodeling and Outcomes in Chronic Aortic Regurgitation
por: Kammerlander, Andreas A., et al.
Publicado: (2020)

Epicardial fat volume is inversely correlated with the degree of diastolic dysfunction and outcome in patients with heart failure with preserved ejection fraction
por: Karakus, Gültekin, et al.
Publicado: (2013)

Isolated Tricuspid Regurgitation and Long-Term Outcome in Patients With Preserved Ejection Fraction
por: Seko, Yuta, et al.
Publicado: (2019)

Diffuse myocardial fibrosis by post-contrast T1-time predicts outcome in heart failure with preserved ejection fraction
por: Marzluf, Beatrice A, et al.
Publicado: (2013)

An Integrated Imaging and Circulating Biomarker Approach for Secondary Tricuspid Regurgitation
por: Spinka, Georg, et al.
Publicado: (2020)

Heart failure with preserved ejection fraction: Calculating the risk of future heart failure events and death
por: Schrutka, Lore, et al.
Publicado: (2022)

Management of tricuspid regurgitation
por: De Bonis, Michele, et al.
Publicado: (2014)

Evaluation of systemic impact of tricuspid regurgitation: an appeal for the notion of tricuspid regurgitation syndrome
por: Lu, Fanglin, et al.
Publicado: (2023)

Transcatheter edge‐to‐edge tricuspid repair for recurrence of valvular regurgitation after left ventricular assist device and tricuspid ring implantation
por: Andreas, Martin, et al.
Publicado: (2020)

Surgical management of tricuspid regurgitation: a new algorithm to minimise recurrent tricuspid regurgitation
por: Rodriguez Torres, Diego, et al.
Publicado: (2022)

A streamlined, machine learning-derived approach to risk-stratification in heart failure patients with secondary tricuspid regurgitation
por: Heitzinger, Gregor, et al.
Publicado: (2023)

Evaluation of the pharmacoDYNAMIC effects of riociguat in subjects with pulmonary hypertension and heart failure with preserved ejection fraction: Study protocol for a randomized controlled trial
por: Mascherbauer, Julia, et al.
Publicado: (2016)

Transcatheter Versus Surgical Valve Repair in Patients with Severe Mitral Regurgitation
por: Koschutnik, Matthias, et al.
Publicado: (2022)

The Conundrum of Tricuspid Regurgitation Grading
por: Go, Yun Yun, et al.
Publicado: (2018)

Jugular Reflux and Tricuspid Regurgitation
por: Gibson, George A.
Publicado: (1880)

Transcatheter Caval Valve Implantation of the Tricento Valve for Tricuspid Regurgitation Using Advanced Intraprocedural Imaging
por: Werner, Paul, et al.
Publicado: (2019)

The impact of tricuspid annular geometry on outcome after percutaneous edge-to-edge repair for severe tricuspid regurgitation
por: Otto, Sylvia, et al.
Publicado: (2021)

Tricuspid valve regurgitation in the presence of endocardial leads – an underestimated problem
por: Rydlewska, Anna, et al.
Publicado: (2017)

Impact of preinterventional tricuspid regurgitation on outcome of MitraClip therapy in patients with severely reduced ejection fraction
por: Gyoten, Takayuki, et al.
Publicado: (2020)

The prevalence, predictors, and prognosis of tricuspid regurgitation in stage B and C heart failure with preserved ejection fraction
por: Ren, Qing‐wen, et al.
Publicado: (2020)

Atrial Functional Tricuspid Regurgitation as a Distinct Pathophysiological and Clinical Entity: No Idiopathic Tricuspid Regurgitation Anymore
por: Florescu, Diana R., et al.
Publicado: (2022)

Tricuspid Regurgitation – Medical Management and Evolving Interventional Concepts
por: Beckhoff, Frederik, et al.
Publicado: (2018)

Right Atrial Phasic Function in Heart Failure with Preserved Ejection Fraction: Cardiac Magnetic Resonance Feature Tracking and Outcomes
por: Schönbauer, Robert, et al.
Publicado: (2023)

Right ventricular dysfunction and tricuspid regurgitation in functional mitral regurgitation
por: Truong, Vien T., et al.
Publicado: (2021)

Tricuspid Edge-to-Edge Repair Versus Tricuspid Valve Replacement for Severe Tricuspid Regurgitation
por: Kim, Jihoon, et al.
Publicado: (2023)

Recent advances in managing tricuspid regurgitation
por: Del Forno, Benedetto, et al.
Publicado: (2018)

Reoperation for isolated rheumatic tricuspid regurgitation
por: Moutakiallah, Younes, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_a4phbsqv09guphse62l7oijebp